US 7341726
Modified HCV peptide immunogens
granted A61KA61K2039/53A61K2039/55522
Quick answer
US patent 7341726 (Modified HCV peptide immunogens) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Mar 06 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Mar 11 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 06 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K2039/53, A61K2039/55522, A61K2039/55538, A61K2039/55566